TABLE 3.
Observed Mean and Median (Q1, Q3) Direct Health Care Expenditures per Plan Member
| Health Care Expenditures, $ | Baselinea | Follow-up Year 1 | Follow-up Year 2 | |||
|---|---|---|---|---|---|---|
| Patients with NTMLD (n = 1,039) | Controls (n = 2,078) | Patients with NTMLD (n = 1,039) | Controls (n = 2,078) | Patients with NTMLD (n = 1,039) | Controls (n = 2,078) | |
| Total health care expendituresb | ||||||
| Mean (SD) | 35,573 ± 61,967 | 5,750 ± 16,964 | 47,713 ± 95,421 | 6,761 ± 20,293 | 29,226 ± 52,141 | 7,231 ± 23,135 |
| Median (Q1, Q3) | 15,627 (6,467, 37,306) | 605 (0, 4,108) | 18,964 (8,170, 53,102) | 770 (0, 5,169) | 11,453 (3,161, 31,600) | 836 (0, 5,147) |
| Pharmacy | ||||||
| Mean (SD) | 8,947 ± 24,294 | 1,380 ± 4,436 | 12,204 ± 26,503 | 1,513 ± 5,821 | 9,191 ± 22746 | 1,743 ± 7,546 |
| Median (Q1, Q3) | 2,354 (593, 6,583) | 22 (0, 1,149) | 4,174 (1,566, 10,594) | 48 (0, 1,219) | 2,430 (175, 7,527) | 58 (0, 1,345) |
| Drug administrationc | ||||||
| Mean (SD) | 3,279 ± 20,075 | 184 ± 1,633 | 4,280 ± 20,785 | 313 ± 2,929 | 2,964 ± 17,252 | 513 ± 5,370 |
| Median (Q1, Q3) | 9 (0, 389) | 0 (0, 0) | 16 (0, 593) | 0 (0, 0) | 0 (0, 192) | 0 (0, 0) |
| Medicalb | ||||||
| Mean (SD) | 26,626 ± 48,461 | 4,370 ± 15,261 | 35,508 ± 86,679 | 5,248 ± 18,195 | 20,036 ± 39,061 | 5,488 ± 19,150 |
| Median (Q1, Q3) | 11,701 (3,821, 27,843) | 209 (0, 2,258) | 12,416 (4,704, 37,141) | 288 (0, 3,029) | 6,715 (1,770, 20,558) | 400 (0, 2,972) |
| Hospitalization | ||||||
| Mean (SD) | 11,505 ± 34,492 | 1,383 ± 9,952 | 18,479 ± 77,387 | 1,995 ± 14,052 | 8,437 ± 26,697 | 1,940 ± 12,030 |
| Median (Q1, Q3) | 0 (0, 8,056) | 0 (0, 0) | 0 (0, 13,494) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) |
| ED | ||||||
| Mean (SD) | 1,070 ± 2,812 | 234 ± 1,130 | 1,273 ± 3,072 | 288 ± 1,379 | 911 ± 2,861 | 308 ± 1,367 |
| Median (Q1, Q3) | 0 (0, 1,063) | 0 (0, 0) | 0 (0, 1,287) | 0 (0, 0) | 0 (0, 498) | 0 (0, 0) |
| Outpatientd | ||||||
| Mean (SD) | 13,574 ± 25,880 | 2,637 ± 8,586 | 14,504 ± 24,785 | 2,845 ± 7,883 | 10,006 ± 19,692 | 3,091 ± 11,929 |
| Median (Q1, Q3) | 7,199 (2,800, 14,864) | 194 (0, 1,929) | 7,701 (3,699, 15,709) | 255 (0, 2,352) | 4,878 (1,402, 11,433) | 372 (0, 2,466) |
| Ancillarye | ||||||
| Mean (SD) | 476 ± 1,946 | 116 ± 787 | 1,252 ± 6,021 | 119 ± 865 | 681± 3,122 | 149 ± 1,023 |
| Median (Q1, Q3) | 0 (0, 0) | 0 (0, 0) | 0 (0, 68) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) |
aBaseline refers to the year before diagnosis.
bTotal health care expenditure = pharmacy expenditure + medical expenditure; medical expenditure = inpatient hospitalization expenditure + ED expenditure + outpatient/office visit expenditure + ancillary care expenditure.
cDrug administration includes outpatient medical claims by clinicians for clinic-based or office-based drug delivery.
dOutpatient includes facility (e.g., laboratory, radiology) and professional services (e.g., pathology, immunizations and injections, rehabilitation).
eAncillary care includes services for medical equipment, home health/hospice visits, services and supplies, and transportation services.
ED = emergency department; NTMLD = nontuberculous mycobacterial lung disease; Q1 = first quartile; Q3 = third quartile; SD = standard deviation.